Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.

Packaging

Date

2026-07-30

Country

Canada

Product

Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2026-08-05
2. CA
   Drugs & medicalType II

   JAMP Methotrexate 10 mg Tablets: Affected lots may contain oversized tablets.

   Product quality

   Health CanadaOfficial notice →
3. 2026-08-04
4. CA
   Drugs & medicalType I

   Needle Kit For Powered Driver

   Performance

   Health CanadaOfficial notice →
5. 2026-07-30
6. CA
   Drugs & medical

   Pharmasave Regular Strength Dairy Digestive Supplement Lactase Enzyme: Affected lot is labelled with the incorrect Natural Product Number (NPN) on the carton.

   Labelling

   Health CanadaOfficial notice →
7. 2026-07-29
8. CA
   Drugs & medicalType II

   Azurion Systems

   Performance

   Health CanadaOfficial notice →
9. 2026-07-28
10. CA
    Drugs & medicalType III

    Oxygen 100%: Gas cylinders containing commercial grade oxygen

    Product quality

    Health CanadaOfficial notice →
11. CA
    Drugs & medicalType II

    Signa MR Systems

    Performance

    Health CanadaOfficial notice →